Propanc Biopharma Inc (PPCB)

$9.60 -0.39 (-3.90%)
Market Cap 193,000.00
Revenue (ttm) 0.00
Net Income (ttm) -1.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.03
Volume 900
Avg Vol 2,876
Day's Range N/A - N/A
Shares Out 19,000.00
Stochastic %K 83%
Beta 2.52
Analysts Strong Buy
Price Target $12.50

Company Profile

Propanc Biopharma, Inc., a biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research collaboration with University of Jaén to carry out a research project aimed at the synthetic development...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9882 0780
Fax: 61 3 9882 9969
Address:
302, 6 Butler Street, Camberwell, Australia
RRCORNER
RRCORNER Jul. 30 at 4:24 PM
$PPCB $PPCB Interesting fact: Stocktwits says 554 investors are following PPCB - the price just doubled - and not one post or comment! Talk about no interest! That's usually when stocks go to ridiculous new highs. They never go up a to when everybody is talking about them. Only when nobody is talking about them. Could PPCB be setting up to run to a hundred soon? Like $RGC ran from $4 to over $900/share in just a few weeks about a month ago.
0 · Reply
RRCORNER
RRCORNER Jul. 29 at 2:16 PM
$PPCB
0 · Reply
Marcovich2000
Marcovich2000 Jul. 26 at 3:47 AM
$PPCB Wow, I can’t believe RRCorner is still here pumping this fraudulent company.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 25 at 12:44 AM
$PPCB Excellent article that nails exactly where PPCB stands right now. So if you want to update your PPCB knowledge or get acquainted with PPCB, this is a must read. https://beyondspx.com/article/propanc-biopharma-a-preclinical-biotech-s-high-stakes-pursuit-of-cancer-recurrence-prevention-ppcb
0 · Reply
Fib7867
Fib7867 Jul. 24 at 7:19 AM
#myPPCBanalysis $PPCB
0 · Reply
RRCORNER
RRCORNER Jul. 24 at 2:49 AM
$PPCB looks like it's ready to fly. PPCB is uplisting to NASDAQ and doing an offering with D. Boral and Craft Capital very soon to start very exciting trials. See link to S1 filing below. PPCB is developing a totally new way to treat cancer that has demonstrated remarkable efficacy and safety. $NWBO $MRK $BMY https://sec.gov/edgar/search/#/ciks=0001517681&entityName=Propanc%2520Biopharma%252C%2520Inc.%2520(PPCB)%2520(CIK%25200001517681)
0 · Reply
RRCORNER
RRCORNER Jun. 30 at 1:31 PM
$PPCB shares are down from $148 in last 12 months. Could they ignite and break this high? Their way to treat cancer is decidedly different. Rather than killing cancer cells, Propanc treats cancer cells to differentiate them which allows them to die a normal death. It looks like it stops metastasis. This could be extraordinary.
0 · Reply
Lum1naCore
Lum1naCore Jun. 25 at 6:46 PM
$PPCB .
0 · Reply
RRCORNER
RRCORNER Jun. 25 at 1:16 AM
$BMY and $MRK and $ABBV looking at promising new way to treat cancer. $PPCB could be blockbuster new drug for these companies. Propanc shares are under $6. https://www.youtube.com/watch?v=JTTCoQACSq0
0 · Reply
RRCORNER
RRCORNER Jun. 22 at 5:42 PM
$PPCB All other cancer therapeutics including immunotherapy and chemotherapy and radiation work by trying to kill cancer cells. Propanc is a totally new MOA that has demonstrated remarkable results on a wide range of cancers and is designed to differentiate cancer cells rather than kill them. This stops metastasis and allows the cancer cells to die natural deaths. What could this be worth? $NWBO $MRK $BMY propanc.com
0 · Reply
Latest News on PPCB
No data available.
RRCORNER
RRCORNER Jul. 30 at 4:24 PM
$PPCB $PPCB Interesting fact: Stocktwits says 554 investors are following PPCB - the price just doubled - and not one post or comment! Talk about no interest! That's usually when stocks go to ridiculous new highs. They never go up a to when everybody is talking about them. Only when nobody is talking about them. Could PPCB be setting up to run to a hundred soon? Like $RGC ran from $4 to over $900/share in just a few weeks about a month ago.
0 · Reply
RRCORNER
RRCORNER Jul. 29 at 2:16 PM
$PPCB
0 · Reply
Marcovich2000
Marcovich2000 Jul. 26 at 3:47 AM
$PPCB Wow, I can’t believe RRCorner is still here pumping this fraudulent company.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 25 at 12:44 AM
$PPCB Excellent article that nails exactly where PPCB stands right now. So if you want to update your PPCB knowledge or get acquainted with PPCB, this is a must read. https://beyondspx.com/article/propanc-biopharma-a-preclinical-biotech-s-high-stakes-pursuit-of-cancer-recurrence-prevention-ppcb
0 · Reply
Fib7867
Fib7867 Jul. 24 at 7:19 AM
#myPPCBanalysis $PPCB
0 · Reply
RRCORNER
RRCORNER Jul. 24 at 2:49 AM
$PPCB looks like it's ready to fly. PPCB is uplisting to NASDAQ and doing an offering with D. Boral and Craft Capital very soon to start very exciting trials. See link to S1 filing below. PPCB is developing a totally new way to treat cancer that has demonstrated remarkable efficacy and safety. $NWBO $MRK $BMY https://sec.gov/edgar/search/#/ciks=0001517681&entityName=Propanc%2520Biopharma%252C%2520Inc.%2520(PPCB)%2520(CIK%25200001517681)
0 · Reply
RRCORNER
RRCORNER Jun. 30 at 1:31 PM
$PPCB shares are down from $148 in last 12 months. Could they ignite and break this high? Their way to treat cancer is decidedly different. Rather than killing cancer cells, Propanc treats cancer cells to differentiate them which allows them to die a normal death. It looks like it stops metastasis. This could be extraordinary.
0 · Reply
Lum1naCore
Lum1naCore Jun. 25 at 6:46 PM
$PPCB .
0 · Reply
RRCORNER
RRCORNER Jun. 25 at 1:16 AM
$BMY and $MRK and $ABBV looking at promising new way to treat cancer. $PPCB could be blockbuster new drug for these companies. Propanc shares are under $6. https://www.youtube.com/watch?v=JTTCoQACSq0
0 · Reply
RRCORNER
RRCORNER Jun. 22 at 5:42 PM
$PPCB All other cancer therapeutics including immunotherapy and chemotherapy and radiation work by trying to kill cancer cells. Propanc is a totally new MOA that has demonstrated remarkable results on a wide range of cancers and is designed to differentiate cancer cells rather than kill them. This stops metastasis and allows the cancer cells to die natural deaths. What could this be worth? $NWBO $MRK $BMY propanc.com
0 · Reply
BullGoPro
BullGoPro Jun. 19 at 5:51 PM
$PPCB .
0 · Reply
camden_brock
camden_brock Jun. 18 at 1:01 PM
$PPCB
0 · Reply
RRCORNER
RRCORNER Jun. 17 at 5:59 PM
$RGC Who cares how it ends? It has already made fortunes for the longs. Next big movers are going to be $PPCB and BLGO.
0 · Reply
PenkeTrading
PenkeTrading Jun. 10 at 4:11 AM
I found you a Three White Soldiers Candle Pattern on the daily chart of Propanc Biopharma Inc. $PPCB #ThreeWhiteSoldiers #PINK
0 · Reply
RiskRewardLab
RiskRewardLab Jun. 5 at 10:02 AM
$PPCB BIOS 🔥🔥🔥🔥 GLMD is on a strong consolidation before catalyst squeeze!! Analyst pt 5-7$. They will be commercializing a product competing against ozempic but in PILLS! Posted about it in the 1.30's and its currently in the 1'50's. Just the start here!
0 · Reply
Moondusterke
Moondusterke Jun. 5 at 5:12 AM
$PPCB 🤔
0 · Reply
RRCORNER
RRCORNER Jun. 4 at 4:41 PM
$PPCB looks like PPCB shares are ready to rise. Totally new way to treat cancer that has been verified in early trials and now they are getting money from large and credible investors. BUY!
0 · Reply
DonCorleone77
DonCorleone77 May. 30 at 8:02 PM
$PPCB Propanc announces offering of 1M shares of common stock, uplisting to Nasdaq Propanc Biopharma is offering 1M shares of common stock. The company is offering each share at an assumed public offering price of $5.00, which is the mid-point of the estimated offering price range between $4.00-$6.00 per share. There is currently a limited public trading market for the common stock, which is currently quoted on the OTC Pink Marketplace operated by the OTC Markets Group under the symbol "PPCB." In connection with this offering, Propanc Biopharma has applied to have its common stock listed on the Nasdaq Capital Market under the symbol "PPCB. If the listing application is not approved by The Nasdaq Stock Market, the company will not consummate the offering and will terminate this offering. The public offering price per share will be determined at the time of pricing and may be at a discount to the current market price. The recent market price used throughout this prospectus may not be indicative of the final offering price. D. Boral Capital and Craft Capital Management are acting as the book-running managers for this offering.
1 · Reply
NimbusBullEdge
NimbusBullEdge May. 28 at 4:51 PM
$PPCB ⁨🚨 JFB Just Set a New 52-Week High - and It Might Be Just the Start 🚨 JFB Construction Holdings (JFB) is on an absolute tear today - now trading at $6.18, up +17.6% intraday, and hitting a fresh 52-week high. 📈 Why the momentum? Here’s what’s fueling the breakout: ✅ $69.5M+ in contracts signed for 2025 - just announced ✅ 93% YoY revenue growth in Q1 2025 ✅ No dilution, no insider selling, tight float ✅ Active construction projects in 36 U.S. states ✅ 100% of business comes from referrals + repeat clients Volume has already blown past the daily average within the first hour - this isn’t hype, it’s real institutional-level interest showing up. This is a micro-cap with a mega-growth profile. If this trajectory continues, double digits aren’t out of the question short term. The float is thin, the tape is hot, and momentum is building FAST. If you’re not watching JFB yet - now’s the time. The stealth phase is over⁩
1 · Reply
RRCORNER
RRCORNER May. 25 at 5:58 PM
$AEHL $BFAC $RMXI $PPCB
0 · Reply
Rexracer13
Rexracer13 May. 22 at 11:32 PM
$PPCB total scam hopefully sec closes it down.
0 · Reply
WaveRider666
WaveRider666 May. 22 at 3:43 PM
$PPCB - So, what does this company do? It toxic dilutes. That's it. That's all. Nothing else.
1 · Reply